Which pricing strategy did Alexion Pharmaceuticals use for Soliris (eculizumab), one of the world's most expensive medications for rare blood disorders?

The pricing of pharmaceutical products involves complex strategies, especially for rare disease treatments known as orphan drugs. These medications treat conditions affecting fewer than 200,000 people in the US, and their pricing models differ significantly from mainstream medications. Test your knowledge about this specialized segment of pharmaceutical pricing that balances research investment, limited patient populations, and healthcare accessibility.

This is a live public trivia poll on AIPolls.Net. Vote and see real-time results.

Value-based pricing reflecting the high cost of life-saving treatment with limited alternatives
Cost-plus pricing based primarily on R&D and manufacturing expenses
Subscription model pricing where hospitals pay annual fees for unlimited access
Indication-specific pricing where cost varies based on which condition is being treated